Therapiemanagement-Anwendung für Hämophilie-Patienten besteht erfolgreich die Rezertifizierung nach EuroPriSe.
Germany based StatConsult Gesellschaft für klinische und Versorgungsforschung mbH is awarded with the European Privacy Seal for its IT-based service Haemoassist® 2 once again.
Haemoassist® 2 is a smart-phone based therapy management application for haemophilia patients and their physicians. It consists of an electronic patient diary (application) in interaction with a web based monitoring-interface for the attending physicians as well as a pharmacy module. Patients may not only use Haemoassist via the smartphone app, but also via a dedicated web interface.
The re-evaluation was performed by EuroPriSe Legal Expert Jörg Joachim Schlißke and by EuroPriSe Technical Expert Tobias Mielke. It took place on the basis of the EuroPriSe Criteria Catalogue for IT-products and IT-based Services (v201701). The evaluators concluded that Haemoassist continues to meet all applicable EuroPriSe requirements. All changes that had been made to the service since the previous recertification in 04/2019 were taken into account during the re-evaluation.
Further information about the 2022 recertification is available here.